Alzheimer's Q&A: Has Aducanumab for Alzheimer's treatment been approved by the FDA?

The Advocate | Acadiana Lafayette

Sep 7, 2020

Aducanumab is an investigative drug therapy for treating Alzheimer's disease from Biogen, an American biotechnology company based in Cambridge, Massachusetts. |!| Lafayette